In April 2011, NUI Galway, with the support of Galway University Foundation, will officially open a new Prostate Cancer Institute. The new Institute, directed by Professor Frank Sullivan, will benefit from a close association between the clinical prostate services ongoing in University Hospital Galway and prostate research in NUI Galway.
Cancer Biology and Therapeutics is a strategic research priority at NUI Galway and over the last number of years, NUI Galway and University Hospital Galway have built a strong team of internationally recognised basic and translational cancer researchers and clinicians. University Hospital Galway is the major academic-medical centre in the west of Ireland, and is now one of the very few hospitals in the country with the capability of providing a full comprehensive cancer service (medical, surgical and radiation oncology) on a single site.
The Prostate Cancer Institute will draw on the expertise of clinicians and scientists from the University and Hospital in an attempt to develop effective drug therapy for patients with relapsed prostate cancer. There is an urgent need for the development of effective drugs for use in this situation, and this is the area in which the new Prostate Cancer Institute hopes to make a serious contribution.
Initial funding for the Institute has been provided by Galway University Foundation. This has enabled the Institute to appoint Dr Sharon Glynn as Director of Research, and it is also in the fortunate position of being able to avail of the expertise of world renowned Professor of Cancer Therapeutics, Frank Giles, as acting scientific director.
Dr Glynn took up her post only on September 1, but already she has been busy, applying for grant funding for specific projects, and also sourcing staff and equipment.
Early work at the Institute will involve the storage and scientific examination of prostate tissue samples. The aim is to see if it is possible to discover (as is already being done with breast cancer) molecular or genetic markers to predict which patients are likely to do badly with the cancer, so that they can be targeted with more than standard treatments. In the longer term, the Institute hopes also to develop the drugs which will augment such standard treatments.
Such work is expensive. As referred to already, the Institute has received initial funding from Galway University Foundation. Ultimately, the intention is to secure long-term financial aid from major national and international scientific and medical funding institutions, but in order to secure such support, the institute needs to establish itself and begin to deliver results.
We, in NUI Galway and Galway University Foundation, sincerely believe the people are in place and the conditions are right for serious results to be delivered. We are excited about the possibilities this venture offers, and we want, with your support, to do everything we can to help this group of committed professionals to make the breakthroughs they believe are possible in the fight against prostate cancer.
To do this however, we need your help. As a Foundation, we can only pass on to the Institute, funds which friends of Galway University donate to us. We would be most grateful therefore, for any contribution you could make. No amount is too small, and we would be delighted to accept either one-off or ongoing payments.
Please consider making a donation to Galway University Foundation for the Prostate Cancer Institute. By helping us to help Frank Sullivan, Sharon Glynn, Frank Giles and their colleagues to make a breakthrough in the fight against prostate cancer, you could even be giving yourself, or someone near and dear to you, the most precious gift of all, the gift of life.
Please click here to support the Prostate Cancer Institute.
For more information, please email Susan Treacy or telephone +353 (0)91 495497.